cbdMD, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from cbdMD, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 5,192% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 94% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-7.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 51% of Healthcare companies in United States.
Cash Locked Ratio
$14For every $100 of sales, $14 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $10 tied up three years earlier.
Less money tied up than 71% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
0/3 · 3/3Sales grew in 0 of the last 3 years; profit grew in 3 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 46%
Sales fell 46% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-46% / -74%In 3 years sales changed by -46% while total assets changed by -74%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-1.9×Operating cash was negative last year, while some debt falls due within a year.
Higher than 64% of Healthcare companies in United States.
Cash Cushion Ratio
+36%Cash, after subtracting all debt, equals 36% of its market value (net cash).
Higher than 71% of Healthcare companies in United States.
Tangible Assets Ratio
80%Of every $100 the company owns, $80 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 51% of Healthcare companies in United States.
Tangible Net Worth Ratio
71%Of every $100 of net worth, $71 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 56% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
cbdMD, Inc. owes $0.38 for every $1 it owns. cbdMD, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
1.6Investors pay $1.6 for every $1 of cbdMD, Inc.'s yearly profit, lower than 91% of Healthcare companies in United States.
P/B ratio
0.51The share price is 0.51 times cbdMD, Inc.'s book value per share, lower than 91% of Healthcare companies in United States.
Market cap
$4 MThe total market value of all of cbdMD, Inc.'s shares at today's price (share price × number of shares), smaller than 94% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$8 MWhat cbdMD, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.73Net worth divided by the number of shares. The share price of $0.37 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-40.3%cbdMD, Inc. lost 40.3% of its shareholders' money over the last year, higher than 54% of Healthcare companies in United States.
Owes vs Owns
0.38×cbdMD, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Dividend yield
NonecbdMD, Inc. does not currently pay a dividend.
Revenue growth
-1%Revenue fell 1% in the year to Sep 2025, and shrank 18% a year on average over 3 years.
Profit growth
LosscbdMD, Inc. made a loss in each of the last two years.
Profit margin
-10.6%cbdMD, Inc. lost $11 for every $100 of revenue.
Cash vs debt
Net cashcbdMD, Inc. held $1 M more cash than debt (net cash) at Sep 2025.
Questions
What is cbdMD, Inc.'s P/E ratio?
Investors pay $1.6 for every $1 of cbdMD, Inc.'s yearly profit, lower than 91% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For cbdMD, Inc.: $4 M ÷ $8 M (30 Jun 2026) = 0.5.
What is cbdMD, Inc.'s return on equity?
cbdMD, Inc. lost 40.3% of its shareholders' money over the last year, higher than 54% of Healthcare companies in United States.
How much does cbdMD, Inc. owe compared with what it owns?
cbdMD, Inc. owes $0.38 for every $1 it owns (low), lower than 53% of Healthcare companies in United States.
Does cbdMD, Inc. pay a dividend?
No. cbdMD, Inc. does not currently pay a dividend.
Is cbdMD, Inc.'s revenue growing?
Revenue fell 1% in the year to Sep 2025, and shrank 18% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.